Medicare Enrolled

Dr. Virginia Smith-Dunwoody, DNP, NP

Nurse Practitioner - Family · Kennewick, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4804 W CLEARWATER AVENUE, Kennewick, WA 99336
5099422355
In practice since 2012 (13 years)
NPI: 1629320874 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Smith-Dunwoody from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith-Dunwoody? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Smith-Dunwoody

Dr. Virginia Smith-Dunwoody is a nurse practitioner - family in Kennewick, WA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Smith-Dunwoody performed 782 Medicare services across 407 unique beneficiaries.

Between the years covered by Open Payments, Dr. Smith-Dunwoody received a total of $248 from 3 pharmaceutical and/or device companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Smith-Dunwoody is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 12% volume in WA $248 industry payments

Medicare Practice Summary

Medicare Utilization ↗
782
Medicare services
Top 12% in WA for nurse practitioner - family
407
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~60 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infectious disease DNA/RNA test
A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism.
384 $34 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
103 $56 $191
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
67 $64 $273
Staphylococcus aureus DNA test
A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample.
38 $34 $50
Yeast/candida DNA test
A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample.
24 $34 $50
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
23 $2 $20
Group B Strep DNA test
A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria.
22 $34 $50
Chlamydia pneumoniae nucleic acid test
A laboratory test that uses amplified probe techniques to detect the genetic material of Chlamydia pneumoniae bacteria in a sample.
19 $34 $50
Mycoplasma pneumoniae nucleic acid test
A laboratory test that uses amplified probe techniques to detect the genetic material of Mycoplasma pneumoniae bacteria.
19 $34 $50
COVID-19 nucleic acid test, high throughput
A laboratory test that detects the genetic material of the SARS-CoV-2 virus using an amplified probe technique. This method utilizes high-throughput technologies to process samples.
15 $74 $185
COVID-19 nucleic acid test, high throughput
A laboratory test that detects the genetic material of the SARS-CoV-2 virus using amplified probe techniques. This method utilizes high-throughput technologies to process samples efficiently.
15 $24 $45
Respiratory virus nucleic acid test, 3-5 targets
A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets.
14 $140 $225
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
14 $50 $105
VRE nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample.
13 $34 $50
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $32 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$248
Total received (2022-2024)
Avg $124/year across 2 years
Top 41% in WA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
3
Companies
14
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$248 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20
2022
$228

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2022-2024) ›
ABBVIE INC.
$191
Biohaven Pharmaceutical Holding Company Ltd.
$37
AstraZeneca Pharmaceuticals LP
$20
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
NURTEC ODT · QULIPTA · UBRELVY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nurse practitioner - family in Kennewick?
Compare family nurse practitioners in the Kennewick area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
116
Per 100K population
55.2
County median income
$87,316
Nearest hospital
TRIOS HEALTH
5.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Smith-Dunwoody is a clinical cardiology specialist, with above-average Medicare volume (top 12% in WA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Smith-Dunwoody experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Smith-Dunwoody performed 384 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Smith-Dunwoody receive payments from pharmaceutical companies?
Yes. Dr. Smith-Dunwoody received a total of $248 from 3 companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smith-Dunwoody's costs compare to other family nurse practitioners in Kennewick?
Dr. Smith-Dunwoody's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smith-Dunwoody) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →